Breastfeeding & Semaglutide: What We Know and Safer Alternatives

Postpartum weight management can be challenging, especially for new mothers who are breastfeeding. Semaglutide, found in medications like Ozempic, Wegovy, and Rybelsus, has shown effectiveness for weight loss and diabetes management—but its safety during lactation is still not fully known. Current research suggests injectable semaglutide has minimal transfer into breast milk, but long-term effects on infants remain unclear. Rapid maternal weight loss may also impact milk supply, so caution is advised. Oral semaglutide (Rybelsus) carries additional risks due to absorption enhancers. Safer alternatives exist, including metformin, insulin, and lifestyle interventions such as balanced nutrition, gradual exercise, and continued breastfeeding. Mothers should work closely with healthcare providers to make informed decisions based on their health needs, infant age, and feeding patterns. Read the full article for detailed insights and guidance